Aveanna Healthcare Secondary Offering of 15M Shares by Selling Stockholders

What Happened

• Aveanna Healthcare Holdings, Inc. filed an 8-K disclosing that certain selling stockholders completed a secondary offering of 15,000,000 shares of the company’s common stock at a public offering price of $11.75 per share. The Underwriting Agreement was entered on August 20, 2026 with RBC Capital Markets, LLC as underwriter and the offering closed on August 24, 2026. The selling stockholders included affiliates of J.H. Whitney Equity Partners VII, LLC and certain current and former directors and officers of the company.
• The filing makes clear that Aveanna did not issue or sell any shares in the offering and therefore did not receive any proceeds. The underwriter was also granted a 30-day option to purchase up to an additional 2,250,000 shares. The Underwriting Agreement is attached as Exhibit 1.1 to the 8-K.

Key Details

• Secondary Offering size: 15,000,000 shares at $11.75 per share.
• Underwriting agreement date: August 20, 2026; offering closed: August 24, 2026.
• Overallotment option: up to 2,250,000 additional shares (30-day option).
• Company impact: Aveanna issued no new shares and received no proceeds from the transaction.

Why It Matters

• Because these were secondary sales by existing holders, Aveanna’s total shares outstanding were not increased and the company did not receive cash from the transaction — so there was no dilution to existing shares and no direct cash benefit to the company.
• The transaction may affect share supply and investor perception because selling parties include a private equity affiliate and current/former company insiders; investors may want to monitor trading volume, float changes, and any further disclosures about additional share sales or exercise of the underwriter’s option.